Trastuzumab Completed Phase 2 Trials for Metastatic Bladder Cancer / Recurrent Bladder Cancer / Transitional Cell Carcinoma of the Bladder Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01828736Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma